Steven van Helden, Chief Technology Officer at Pivot Park Screening Centre (PPSC), relies on efficient microplate readers for effective hit discovery. Here he discusses innovation in drug discovery and the future of screening technology. In what way is the drug discovery environment changing and how does it affect your work? Open innovation and knowledge exchange have become topics of great relevance in the last couple of years and have proven to accelerate drug discoveries. At PPSC we’ve been..
